nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—AQP1—oviduct—uterine cancer	0.0551	0.127	CbGeAlD
Acetazolamide—AQP1—exocrine gland—uterine cancer	0.0318	0.0736	CbGeAlD
Acetazolamide—CA6—exocrine gland—uterine cancer	0.0246	0.057	CbGeAlD
Acetazolamide—Growth retardation—Dactinomycin—uterine cancer	0.024	0.044	CcSEcCtD
Acetazolamide—AQP1—myometrium—uterine cancer	0.0176	0.0408	CbGeAlD
Acetazolamide—AQP1—epithelium—uterine cancer	0.0138	0.032	CbGeAlD
Acetazolamide—AQP1—uterine cervix—uterine cancer	0.0137	0.0317	CbGeAlD
Acetazolamide—AQP1—smooth muscle tissue—uterine cancer	0.0133	0.0308	CbGeAlD
Acetazolamide—Hepatic necrosis—Progesterone—uterine cancer	0.0133	0.0243	CcSEcCtD
Acetazolamide—AQP1—decidua—uterine cancer	0.0131	0.0302	CbGeAlD
Acetazolamide—CA3—myometrium—uterine cancer	0.0129	0.0299	CbGeAlD
Acetazolamide—AQP1—renal system—uterine cancer	0.0128	0.0297	CbGeAlD
Acetazolamide—AQP1—endometrium—uterine cancer	0.0124	0.0287	CbGeAlD
Acetazolamide—CA5A—female reproductive system—uterine cancer	0.0123	0.0286	CbGeAlD
Acetazolamide—AQP1—mammalian vulva—uterine cancer	0.012	0.0278	CbGeAlD
Acetazolamide—Digestion impaired—Progesterone—uterine cancer	0.0115	0.0212	CcSEcCtD
Acetazolamide—AQP1—uterus—uterine cancer	0.0114	0.0265	CbGeAlD
Acetazolamide—Digestion impaired—Medroxyprogesterone Acetate—uterine cancer	0.0105	0.0192	CcSEcCtD
Acetazolamide—AQP1—female reproductive system—uterine cancer	0.0103	0.0238	CbGeAlD
Acetazolamide—CA7—renal system—uterine cancer	0.0103	0.0237	CbGeAlD
Acetazolamide—CA3—uterine cervix—uterine cancer	0.0101	0.0233	CbGeAlD
Acetazolamide—Metabolic acidosis—Etoposide—uterine cancer	0.00999	0.0183	CcSEcCtD
Acetazolamide—AQP1—female gonad—uterine cancer	0.00935	0.0216	CbGeAlD
Acetazolamide—AQP1—vagina—uterine cancer	0.00929	0.0215	CbGeAlD
Acetazolamide—Jaundice cholestatic—Progesterone—uterine cancer	0.00878	0.0161	CcSEcCtD
Acetazolamide—Glycosuria—Medroxyprogesterone Acetate—uterine cancer	0.00863	0.0158	CcSEcCtD
Acetazolamide—Injection site pain—Medroxyprogesterone Acetate—uterine cancer	0.00856	0.0157	CcSEcCtD
Acetazolamide—CA2—exocrine gland—uterine cancer	0.00848	0.0196	CbGeAlD
Acetazolamide—CA3—uterus—uterine cancer	0.00838	0.0194	CbGeAlD
Acetazolamide—Blood disorder—Medroxyprogesterone Acetate—uterine cancer	0.00837	0.0153	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.00796	0.0146	CcSEcCtD
Acetazolamide—CA9—female reproductive system—uterine cancer	0.00721	0.0167	CbGeAlD
Acetazolamide—CA3—vagina—uterine cancer	0.00681	0.0158	CbGeAlD
Acetazolamide—CA12—renal system—uterine cancer	0.00666	0.0154	CbGeAlD
Acetazolamide—Hepatic function abnormal—Progesterone—uterine cancer	0.00641	0.0118	CcSEcCtD
Acetazolamide—Hepatic failure—Progesterone—uterine cancer	0.00623	0.0114	CcSEcCtD
Acetazolamide—AQP1—lymph node—uterine cancer	0.00601	0.0139	CbGeAlD
Acetazolamide—Thirst—Progesterone—uterine cancer	0.00589	0.0108	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00581	0.0106	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Progesterone—uterine cancer	0.00579	0.0106	CcSEcCtD
Acetazolamide—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.00565	0.0104	CcSEcCtD
Acetazolamide—CA5B—mammalian vulva—uterine cancer	0.00559	0.0129	CbGeAlD
Acetazolamide—Irritability—Progesterone—uterine cancer	0.00535	0.0098	CcSEcCtD
Acetazolamide—CA12—female reproductive system—uterine cancer	0.00534	0.0124	CbGeAlD
Acetazolamide—Thirst—Medroxyprogesterone Acetate—uterine cancer	0.00533	0.00978	CcSEcCtD
Acetazolamide—CA1—renal system—uterine cancer	0.00528	0.0122	CbGeAlD
Acetazolamide—Anaphylactoid reaction—Medroxyprogesterone Acetate—uterine cancer	0.00524	0.00961	CcSEcCtD
Acetazolamide—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.0052	0.00954	CcSEcCtD
Acetazolamide—Aplastic anaemia—Dactinomycin—uterine cancer	0.00512	0.00939	CcSEcCtD
Acetazolamide—Tingling sensation—Etoposide—uterine cancer	0.00491	0.009	CcSEcCtD
Acetazolamide—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00484	0.00888	CcSEcCtD
Acetazolamide—CA5B—female reproductive system—uterine cancer	0.00479	0.0111	CbGeAlD
Acetazolamide—Ataxia—Medroxyprogesterone Acetate—uterine cancer	0.00477	0.00875	CcSEcCtD
Acetazolamide—Numbness—Etoposide—uterine cancer	0.00476	0.00873	CcSEcCtD
Acetazolamide—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00462	0.00847	CcSEcCtD
Acetazolamide—Sensory loss—Etoposide—uterine cancer	0.00456	0.00835	CcSEcCtD
Acetazolamide—CA3—lymph node—uterine cancer	0.00441	0.0102	CbGeAlD
Acetazolamide—Hepatic failure—Dactinomycin—uterine cancer	0.0044	0.00808	CcSEcCtD
Acetazolamide—CA5B—vagina—uterine cancer	0.00433	0.01	CbGeAlD
Acetazolamide—Drowsiness—Progesterone—uterine cancer	0.00432	0.00791	CcSEcCtD
Acetazolamide—CA1—female reproductive system—uterine cancer	0.00423	0.00978	CbGeAlD
Acetazolamide—Body temperature increased—Carboplatin—uterine cancer	0.00414	0.0076	CcSEcCtD
Acetazolamide—CA4—renal system—uterine cancer	0.00413	0.00955	CbGeAlD
Acetazolamide—Hepatobiliary disease—Progesterone—uterine cancer	0.00408	0.00748	CcSEcCtD
Acetazolamide—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00391	0.00717	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Medroxyprogesterone Acetate—uterine cancer	0.0037	0.00678	CcSEcCtD
Acetazolamide—CA2—epithelium—uterine cancer	0.00369	0.00854	CbGeAlD
Acetazolamide—Erythema multiforme—Progesterone—uterine cancer	0.00366	0.00672	CcSEcCtD
Acetazolamide—Tinnitus—Progesterone—uterine cancer	0.00361	0.00662	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.00356	0.00654	CcSEcCtD
Acetazolamide—CA2—smooth muscle tissue—uterine cancer	0.00355	0.00823	CbGeAlD
Acetazolamide—CA2—decidua—uterine cancer	0.00348	0.00806	CbGeAlD
Acetazolamide—CA2—renal system—uterine cancer	0.00342	0.00792	CbGeAlD
Acetazolamide—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00332	0.00609	CcSEcCtD
Acetazolamide—CA4—female reproductive system—uterine cancer	0.0033	0.00765	CbGeAlD
Acetazolamide—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00327	0.006	CcSEcCtD
Acetazolamide—CA2—mammalian vulva—uterine cancer	0.0032	0.0074	CbGeAlD
Acetazolamide—Ill-defined disorder—Progesterone—uterine cancer	0.00313	0.00574	CcSEcCtD
Acetazolamide—Malaise—Progesterone—uterine cancer	0.00304	0.00558	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00302	0.00555	CcSEcCtD
Acetazolamide—CA4—female gonad—uterine cancer	0.00301	0.00696	CbGeAlD
Acetazolamide—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00299	0.00549	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Etoposide—uterine cancer	0.00296	0.00543	CcSEcCtD
Acetazolamide—Convulsion—Progesterone—uterine cancer	0.00292	0.00536	CcSEcCtD
Acetazolamide—Agranulocytosis—Dactinomycin—uterine cancer	0.00285	0.00522	CcSEcCtD
Acetazolamide—Discomfort—Progesterone—uterine cancer	0.00284	0.0052	CcSEcCtD
Acetazolamide—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.0052	CcSEcCtD
Acetazolamide—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00281	0.00515	CcSEcCtD
Acetazolamide—CA5B—lymph node—uterine cancer	0.0028	0.00648	CbGeAlD
Acetazolamide—Confusional state—Progesterone—uterine cancer	0.00278	0.00509	CcSEcCtD
Acetazolamide—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00276	0.00505	CcSEcCtD
Acetazolamide—Anaphylactic shock—Progesterone—uterine cancer	0.00275	0.00505	CcSEcCtD
Acetazolamide—CA2—female reproductive system—uterine cancer	0.00274	0.00634	CbGeAlD
Acetazolamide—Glycosuria—Epirubicin—uterine cancer	0.00273	0.00501	CcSEcCtD
Acetazolamide—Injection site pain—Epirubicin—uterine cancer	0.00271	0.00497	CcSEcCtD
Acetazolamide—Shock—Progesterone—uterine cancer	0.00271	0.00497	CcSEcCtD
Acetazolamide—Blood disorder—Epirubicin—uterine cancer	0.00265	0.00486	CcSEcCtD
Acetazolamide—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00265	0.00486	CcSEcCtD
Acetazolamide—Erythema multiforme—Dactinomycin—uterine cancer	0.00259	0.00475	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00258	0.00473	CcSEcCtD
Acetazolamide—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00257	0.00471	CcSEcCtD
Acetazolamide—Flushing—Dactinomycin—uterine cancer	0.00254	0.00466	CcSEcCtD
Acetazolamide—Glycosuria—Doxorubicin—uterine cancer	0.00253	0.00463	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Epirubicin—uterine cancer	0.00252	0.00462	CcSEcCtD
Acetazolamide—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00461	CcSEcCtD
Acetazolamide—Injection site pain—Doxorubicin—uterine cancer	0.00251	0.0046	CcSEcCtD
Acetazolamide—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00249	0.00457	CcSEcCtD
Acetazolamide—CA2—female gonad—uterine cancer	0.00249	0.00577	CbGeAlD
Acetazolamide—CA2—vagina—uterine cancer	0.00248	0.00574	CbGeAlD
Acetazolamide—CA1—lymph node—uterine cancer	0.00247	0.00572	CbGeAlD
Acetazolamide—Paraesthesia—Progesterone—uterine cancer	0.00247	0.00453	CcSEcCtD
Acetazolamide—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00245	0.0045	CcSEcCtD
Acetazolamide—Blood disorder—Doxorubicin—uterine cancer	0.00245	0.00449	CcSEcCtD
Acetazolamide—Somnolence—Progesterone—uterine cancer	0.00245	0.00449	CcSEcCtD
Acetazolamide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00244	0.00448	CcSEcCtD
Acetazolamide—Dyspepsia—Progesterone—uterine cancer	0.00242	0.00444	CcSEcCtD
Acetazolamide—Decreased appetite—Progesterone—uterine cancer	0.00239	0.00439	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Progesterone—uterine cancer	0.00238	0.00436	CcSEcCtD
Acetazolamide—Fatigue—Progesterone—uterine cancer	0.00237	0.00435	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Doxorubicin—uterine cancer	0.00233	0.00427	CcSEcCtD
Acetazolamide—Feeling abnormal—Progesterone—uterine cancer	0.00227	0.00416	CcSEcCtD
Acetazolamide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00224	0.00411	CcSEcCtD
Acetazolamide—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00222	0.00407	CcSEcCtD
Acetazolamide—Ill-defined disorder—Dactinomycin—uterine cancer	0.00221	0.00406	CcSEcCtD
Acetazolamide—CYP3A4—renal system—uterine cancer	0.00221	0.00511	CbGeAlD
Acetazolamide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.0022	0.00403	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00219	0.00401	CcSEcCtD
Acetazolamide—Urticaria—Progesterone—uterine cancer	0.00219	0.00401	CcSEcCtD
Acetazolamide—Body temperature increased—Progesterone—uterine cancer	0.00218	0.00399	CcSEcCtD
Acetazolamide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00217	0.00398	CcSEcCtD
Acetazolamide—Melaena—Epirubicin—uterine cancer	0.00216	0.00396	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00215	0.00395	CcSEcCtD
Acetazolamide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00215	0.00394	CcSEcCtD
Acetazolamide—Malaise—Dactinomycin—uterine cancer	0.00215	0.00394	CcSEcCtD
Acetazolamide—Leukopenia—Dactinomycin—uterine cancer	0.00213	0.00391	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Etoposide—uterine cancer	0.00209	0.00383	CcSEcCtD
Acetazolamide—Aplastic anaemia—Epirubicin—uterine cancer	0.00208	0.00381	CcSEcCtD
Acetazolamide—Agranulocytosis—Etoposide—uterine cancer	0.00206	0.00378	CcSEcCtD
Acetazolamide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00206	0.00377	CcSEcCtD
Acetazolamide—Discomfort—Dactinomycin—uterine cancer	0.00201	0.00368	CcSEcCtD
Acetazolamide—Melaena—Doxorubicin—uterine cancer	0.002	0.00367	CcSEcCtD
Acetazolamide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.00363	CcSEcCtD
Acetazolamide—Asthenia—Progesterone—uterine cancer	0.00198	0.00362	CcSEcCtD
Acetazolamide—Hypoaesthesia—Etoposide—uterine cancer	0.00197	0.00362	CcSEcCtD
Acetazolamide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00197	0.00362	CcSEcCtD
Acetazolamide—CA4—lymph node—uterine cancer	0.00193	0.00447	CbGeAlD
Acetazolamide—Aplastic anaemia—Doxorubicin—uterine cancer	0.00192	0.00352	CcSEcCtD
Acetazolamide—Thrombocytopenia—Dactinomycin—uterine cancer	0.00191	0.00349	CcSEcCtD
Acetazolamide—Diarrhoea—Progesterone—uterine cancer	0.00188	0.00345	CcSEcCtD
Acetazolamide—Erythema multiforme—Etoposide—uterine cancer	0.00187	0.00344	CcSEcCtD
Acetazolamide—Flushing—Etoposide—uterine cancer	0.00184	0.00337	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Epirubicin—uterine cancer	0.00184	0.00337	CcSEcCtD
Acetazolamide—Photosensitivity—Epirubicin—uterine cancer	0.00183	0.00335	CcSEcCtD
Acetazolamide—Dizziness—Progesterone—uterine cancer	0.00182	0.00334	CcSEcCtD
Acetazolamide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00328	CcSEcCtD
Acetazolamide—Hepatic failure—Epirubicin—uterine cancer	0.00179	0.00328	CcSEcCtD
Acetazolamide—CYP3A4—female reproductive system—uterine cancer	0.00177	0.00409	CbGeAlD
Acetazolamide—Vomiting—Progesterone—uterine cancer	0.00175	0.00321	CcSEcCtD
Acetazolamide—Headache—Progesterone—uterine cancer	0.00172	0.00316	CcSEcCtD
Acetazolamide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00313	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Doxorubicin—uterine cancer	0.0017	0.00312	CcSEcCtD
Acetazolamide—Photosensitivity—Doxorubicin—uterine cancer	0.00169	0.0031	CcSEcCtD
Acetazolamide—Decreased appetite—Dactinomycin—uterine cancer	0.00169	0.0031	CcSEcCtD
Acetazolamide—Dysgeusia—Etoposide—uterine cancer	0.00169	0.0031	CcSEcCtD
Acetazolamide—Fatigue—Dactinomycin—uterine cancer	0.00168	0.00308	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00166	0.00304	CcSEcCtD
Acetazolamide—Hepatic failure—Doxorubicin—uterine cancer	0.00165	0.00303	CcSEcCtD
Acetazolamide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00302	CcSEcCtD
Acetazolamide—Hypoglycaemia—Epirubicin—uterine cancer	0.00165	0.00302	CcSEcCtD
Acetazolamide—Nausea—Progesterone—uterine cancer	0.00164	0.003	CcSEcCtD
Acetazolamide—Hyponatraemia—Epirubicin—uterine cancer	0.00161	0.00296	CcSEcCtD
Acetazolamide—Feeling abnormal—Dactinomycin—uterine cancer	0.0016	0.00294	CcSEcCtD
Acetazolamide—CA2—lymph node—uterine cancer	0.0016	0.00371	CbGeAlD
Acetazolamide—Ill-defined disorder—Etoposide—uterine cancer	0.0016	0.00294	CcSEcCtD
Acetazolamide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00159	0.00291	CcSEcCtD
Acetazolamide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00156	0.00287	CcSEcCtD
Acetazolamide—Malaise—Etoposide—uterine cancer	0.00156	0.00285	CcSEcCtD
Acetazolamide—Leukopenia—Etoposide—uterine cancer	0.00154	0.00283	CcSEcCtD
Acetazolamide—Body temperature increased—Dactinomycin—uterine cancer	0.00154	0.00282	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.00154	0.00282	CcSEcCtD
Acetazolamide—Hypoglycaemia—Doxorubicin—uterine cancer	0.00152	0.00279	CcSEcCtD
Acetazolamide—Ataxia—Epirubicin—uterine cancer	0.00151	0.00277	CcSEcCtD
Acetazolamide—Convulsion—Etoposide—uterine cancer	0.00149	0.00274	CcSEcCtD
Acetazolamide—Hyponatraemia—Doxorubicin—uterine cancer	0.00149	0.00274	CcSEcCtD
Acetazolamide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.00272	CcSEcCtD
Acetazolamide—Hypokalaemia—Epirubicin—uterine cancer	0.00146	0.00268	CcSEcCtD
Acetazolamide—Discomfort—Etoposide—uterine cancer	0.00145	0.00266	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00145	0.00265	CcSEcCtD
Acetazolamide—Confusional state—Etoposide—uterine cancer	0.00142	0.0026	CcSEcCtD
Acetazolamide—Anaphylactic shock—Etoposide—uterine cancer	0.00141	0.00258	CcSEcCtD
Acetazolamide—Ataxia—Doxorubicin—uterine cancer	0.0014	0.00256	CcSEcCtD
Acetazolamide—Asthenia—Dactinomycin—uterine cancer	0.0014	0.00256	CcSEcCtD
Acetazolamide—Thrombocytopenia—Etoposide—uterine cancer	0.00138	0.00253	CcSEcCtD
Acetazolamide—Hypokalaemia—Doxorubicin—uterine cancer	0.00135	0.00248	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00134	0.00245	CcSEcCtD
Acetazolamide—Diarrhoea—Dactinomycin—uterine cancer	0.00133	0.00244	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Epirubicin—uterine cancer	0.00127	0.00232	CcSEcCtD
Acetazolamide—Paraesthesia—Etoposide—uterine cancer	0.00126	0.00232	CcSEcCtD
Acetazolamide—Somnolence—Etoposide—uterine cancer	0.00125	0.0023	CcSEcCtD
Acetazolamide—Drowsiness—Epirubicin—uterine cancer	0.00124	0.00227	CcSEcCtD
Acetazolamide—Vomiting—Dactinomycin—uterine cancer	0.00124	0.00227	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00123	0.00225	CcSEcCtD
Acetazolamide—Decreased appetite—Etoposide—uterine cancer	0.00122	0.00224	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Etoposide—uterine cancer	0.00122	0.00223	CcSEcCtD
Acetazolamide—Fatigue—Etoposide—uterine cancer	0.00121	0.00223	CcSEcCtD
Acetazolamide—Haematuria—Epirubicin—uterine cancer	0.00118	0.00216	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00117	0.00215	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Epirubicin—uterine cancer	0.00117	0.00215	CcSEcCtD
Acetazolamide—Feeling abnormal—Etoposide—uterine cancer	0.00116	0.00213	CcSEcCtD
Acetazolamide—Nausea—Dactinomycin—uterine cancer	0.00116	0.00212	CcSEcCtD
Acetazolamide—Agranulocytosis—Epirubicin—uterine cancer	0.00115	0.00212	CcSEcCtD
Acetazolamide—Drowsiness—Doxorubicin—uterine cancer	0.00115	0.0021	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00114	0.00208	CcSEcCtD
Acetazolamide—Urticaria—Etoposide—uterine cancer	0.00112	0.00205	CcSEcCtD
Acetazolamide—Body temperature increased—Etoposide—uterine cancer	0.00111	0.00204	CcSEcCtD
Acetazolamide—Hypoaesthesia—Epirubicin—uterine cancer	0.00111	0.00203	CcSEcCtD
Acetazolamide—Haematuria—Doxorubicin—uterine cancer	0.00109	0.002	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Doxorubicin—uterine cancer	0.00108	0.00199	CcSEcCtD
Acetazolamide—Agranulocytosis—Doxorubicin—uterine cancer	0.00107	0.00196	CcSEcCtD
Acetazolamide—Erythema multiforme—Epirubicin—uterine cancer	0.00105	0.00193	CcSEcCtD
Acetazolamide—Tinnitus—Epirubicin—uterine cancer	0.00104	0.0019	CcSEcCtD
Acetazolamide—Flushing—Epirubicin—uterine cancer	0.00103	0.00189	CcSEcCtD
Acetazolamide—Hypoaesthesia—Doxorubicin—uterine cancer	0.00102	0.00188	CcSEcCtD
Acetazolamide—Asthenia—Etoposide—uterine cancer	0.00101	0.00185	CcSEcCtD
Acetazolamide—Erythema multiforme—Doxorubicin—uterine cancer	0.000972	0.00178	CcSEcCtD
Acetazolamide—Diarrhoea—Etoposide—uterine cancer	0.000963	0.00177	CcSEcCtD
Acetazolamide—Tinnitus—Doxorubicin—uterine cancer	0.000958	0.00176	CcSEcCtD
Acetazolamide—Flushing—Doxorubicin—uterine cancer	0.000954	0.00175	CcSEcCtD
Acetazolamide—Dysgeusia—Epirubicin—uterine cancer	0.000947	0.00174	CcSEcCtD
Acetazolamide—Dizziness—Etoposide—uterine cancer	0.000931	0.00171	CcSEcCtD
Acetazolamide—Ill-defined disorder—Epirubicin—uterine cancer	0.000897	0.00165	CcSEcCtD
Acetazolamide—Vomiting—Etoposide—uterine cancer	0.000895	0.00164	CcSEcCtD
Acetazolamide—Agitation—Epirubicin—uterine cancer	0.000889	0.00163	CcSEcCtD
Acetazolamide—Headache—Etoposide—uterine cancer	0.000882	0.00162	CcSEcCtD
Acetazolamide—Dysgeusia—Doxorubicin—uterine cancer	0.000876	0.00161	CcSEcCtD
Acetazolamide—Malaise—Epirubicin—uterine cancer	0.000872	0.0016	CcSEcCtD
Acetazolamide—Leukopenia—Epirubicin—uterine cancer	0.000866	0.00159	CcSEcCtD
Acetazolamide—Convulsion—Epirubicin—uterine cancer	0.000838	0.00154	CcSEcCtD
Acetazolamide—Nausea—Etoposide—uterine cancer	0.000836	0.00153	CcSEcCtD
Acetazolamide—Ill-defined disorder—Doxorubicin—uterine cancer	0.00083	0.00152	CcSEcCtD
Acetazolamide—Agitation—Doxorubicin—uterine cancer	0.000822	0.00151	CcSEcCtD
Acetazolamide—Discomfort—Epirubicin—uterine cancer	0.000814	0.00149	CcSEcCtD
Acetazolamide—Malaise—Doxorubicin—uterine cancer	0.000807	0.00148	CcSEcCtD
Acetazolamide—Leukopenia—Doxorubicin—uterine cancer	0.000801	0.00147	CcSEcCtD
Acetazolamide—Confusional state—Epirubicin—uterine cancer	0.000796	0.00146	CcSEcCtD
Acetazolamide—Anaphylactic shock—Epirubicin—uterine cancer	0.000789	0.00145	CcSEcCtD
Acetazolamide—Shock—Epirubicin—uterine cancer	0.000777	0.00142	CcSEcCtD
Acetazolamide—Convulsion—Doxorubicin—uterine cancer	0.000775	0.00142	CcSEcCtD
Acetazolamide—Thrombocytopenia—Epirubicin—uterine cancer	0.000773	0.00142	CcSEcCtD
Acetazolamide—Discomfort—Doxorubicin—uterine cancer	0.000753	0.00138	CcSEcCtD
Acetazolamide—Confusional state—Doxorubicin—uterine cancer	0.000736	0.00135	CcSEcCtD
Acetazolamide—Anaphylactic shock—Doxorubicin—uterine cancer	0.00073	0.00134	CcSEcCtD
Acetazolamide—Shock—Doxorubicin—uterine cancer	0.000719	0.00132	CcSEcCtD
Acetazolamide—Thrombocytopenia—Doxorubicin—uterine cancer	0.000715	0.00131	CcSEcCtD
Acetazolamide—Paraesthesia—Epirubicin—uterine cancer	0.000709	0.0013	CcSEcCtD
Acetazolamide—Somnolence—Epirubicin—uterine cancer	0.000702	0.00129	CcSEcCtD
Acetazolamide—Dyspepsia—Epirubicin—uterine cancer	0.000695	0.00127	CcSEcCtD
Acetazolamide—Decreased appetite—Epirubicin—uterine cancer	0.000686	0.00126	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000681	0.00125	CcSEcCtD
Acetazolamide—Fatigue—Epirubicin—uterine cancer	0.000681	0.00125	CcSEcCtD
Acetazolamide—Paraesthesia—Doxorubicin—uterine cancer	0.000656	0.0012	CcSEcCtD
Acetazolamide—Feeling abnormal—Epirubicin—uterine cancer	0.00065	0.00119	CcSEcCtD
Acetazolamide—Somnolence—Doxorubicin—uterine cancer	0.000649	0.00119	CcSEcCtD
Acetazolamide—Dyspepsia—Doxorubicin—uterine cancer	0.000643	0.00118	CcSEcCtD
Acetazolamide—Decreased appetite—Doxorubicin—uterine cancer	0.000635	0.00116	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000631	0.00116	CcSEcCtD
Acetazolamide—Fatigue—Doxorubicin—uterine cancer	0.00063	0.00115	CcSEcCtD
Acetazolamide—Urticaria—Epirubicin—uterine cancer	0.000627	0.00115	CcSEcCtD
Acetazolamide—Body temperature increased—Epirubicin—uterine cancer	0.000624	0.00114	CcSEcCtD
Acetazolamide—Feeling abnormal—Doxorubicin—uterine cancer	0.000602	0.0011	CcSEcCtD
Acetazolamide—Urticaria—Doxorubicin—uterine cancer	0.00058	0.00106	CcSEcCtD
Acetazolamide—Body temperature increased—Doxorubicin—uterine cancer	0.000577	0.00106	CcSEcCtD
Acetazolamide—Asthenia—Epirubicin—uterine cancer	0.000566	0.00104	CcSEcCtD
Acetazolamide—Diarrhoea—Epirubicin—uterine cancer	0.00054	0.00099	CcSEcCtD
Acetazolamide—Asthenia—Doxorubicin—uterine cancer	0.000524	0.000961	CcSEcCtD
Acetazolamide—Dizziness—Epirubicin—uterine cancer	0.000522	0.000957	CcSEcCtD
Acetazolamide—Vomiting—Epirubicin—uterine cancer	0.000502	0.00092	CcSEcCtD
Acetazolamide—Diarrhoea—Doxorubicin—uterine cancer	0.0005	0.000916	CcSEcCtD
Acetazolamide—Headache—Epirubicin—uterine cancer	0.000495	0.000907	CcSEcCtD
Acetazolamide—Dizziness—Doxorubicin—uterine cancer	0.000483	0.000886	CcSEcCtD
Acetazolamide—Nausea—Epirubicin—uterine cancer	0.000469	0.00086	CcSEcCtD
Acetazolamide—Vomiting—Doxorubicin—uterine cancer	0.000464	0.000851	CcSEcCtD
Acetazolamide—Headache—Doxorubicin—uterine cancer	0.000458	0.000839	CcSEcCtD
Acetazolamide—Nausea—Doxorubicin—uterine cancer	0.000434	0.000795	CcSEcCtD
Acetazolamide—CA9—Cellular responses to stress—GPX3—uterine cancer	0.000171	0.00758	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—CDKN2A—uterine cancer	0.000171	0.00755	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—POLD1—uterine cancer	0.000166	0.00733	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—NDUFB11—uterine cancer	0.000163	0.00722	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—SRD5A2—uterine cancer	0.000163	0.00722	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—NDUFB11—uterine cancer	0.000159	0.00703	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—SRD5A2—uterine cancer	0.000159	0.00703	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—NDUFB11—uterine cancer	0.000159	0.00703	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—SRD5A2—uterine cancer	0.000159	0.00703	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—AKR1C1—uterine cancer	0.000155	0.00686	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—CDKN1B—uterine cancer	0.000151	0.00669	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—NDUFB11—uterine cancer	0.000148	0.00657	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—NDUFB11—uterine cancer	0.000148	0.00657	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—SRD5A2—uterine cancer	0.000148	0.00657	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—SRD5A2—uterine cancer	0.000148	0.00657	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—HMGA1—uterine cancer	0.000146	0.00648	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—POLD1—uterine cancer	0.000144	0.00636	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—EP300—uterine cancer	0.000141	0.00626	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—YWHAE—uterine cancer	0.00014	0.00618	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—EZH2—uterine cancer	0.000139	0.00615	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—RRM2—uterine cancer	0.000138	0.00611	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—NDUFB11—uterine cancer	0.000137	0.00608	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—SRD5A2—uterine cancer	0.000137	0.00608	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—AKR1C1—uterine cancer	0.000134	0.00594	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—DCN—uterine cancer	0.000134	0.00593	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	0.000134	0.00593	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—EP300—uterine cancer	0.000133	0.00587	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CYP11A1—uterine cancer	0.000126	0.00559	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—NRAS—uterine cancer	0.000124	0.00549	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—RRM2—uterine cancer	0.00012	0.0053	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—AKR1C3—uterine cancer	0.000119	0.00528	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—STAR—uterine cancer	0.000118	0.00522	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKR1B1—uterine cancer	0.000118	0.00522	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—DCN—uterine cancer	0.000116	0.00514	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKR1B1—uterine cancer	0.000115	0.00509	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—STAR—uterine cancer	0.000115	0.00509	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKR1B1—uterine cancer	0.000115	0.00509	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—STAR—uterine cancer	0.000115	0.00509	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—SRD5A2—uterine cancer	0.00011	0.00485	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—NDUFB11—uterine cancer	0.00011	0.00485	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CYP11A1—uterine cancer	0.000109	0.00485	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—STAR—uterine cancer	0.000107	0.00475	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKR1B1—uterine cancer	0.000107	0.00475	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKR1B1—uterine cancer	0.000107	0.00475	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—STAR—uterine cancer	0.000107	0.00475	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—KRAS—uterine cancer	0.000107	0.00473	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—NDUFB11—uterine cancer	0.000105	0.00465	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SRD5A2—uterine cancer	0.000105	0.00465	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN2B—uterine cancer	0.000105	0.00464	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—AKR1C3—uterine cancer	0.000103	0.00458	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—NDUFB11—uterine cancer	0.000101	0.00446	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SRD5A2—uterine cancer	0.000101	0.00446	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKR1B1—uterine cancer	9.94e-05	0.0044	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—STAR—uterine cancer	9.94e-05	0.0044	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—STK11—uterine cancer	9.29e-05	0.00411	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CYP19A1—uterine cancer	9.29e-05	0.00411	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—POLD1—uterine cancer	9.25e-05	0.0041	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—HRAS—uterine cancer	9.08e-05	0.00402	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—POLD1—uterine cancer	9.02e-05	0.00399	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—POLD1—uterine cancer	9.02e-05	0.00399	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—NDUFB11—uterine cancer	8.86e-05	0.00392	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SRD5A2—uterine cancer	8.86e-05	0.00392	CbGpPWpGaD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	8.76e-05	0.00388	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKR1C1—uterine cancer	8.66e-05	0.00383	CbGpPWpGaD
Acetazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	8.65e-05	0.00383	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—AKT1—uterine cancer	8.55e-05	0.00378	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKR1C1—uterine cancer	8.44e-05	0.00373	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKR1C1—uterine cancer	8.44e-05	0.00373	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—POLD1—uterine cancer	8.42e-05	0.00373	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—POLD1—uterine cancer	8.42e-05	0.00373	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ABCC9—uterine cancer	8.2e-05	0.00363	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—STK11—uterine cancer	8.06e-05	0.00357	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CYP19A1—uterine cancer	8.06e-05	0.00357	CbGpPWpGaD
Acetazolamide—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	7.97e-05	0.00353	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—STAR—uterine cancer	7.93e-05	0.00351	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKR1B1—uterine cancer	7.93e-05	0.00351	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKR1C1—uterine cancer	7.87e-05	0.00349	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKR1C1—uterine cancer	7.87e-05	0.00349	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—POLD1—uterine cancer	7.8e-05	0.00345	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—RRM2—uterine cancer	7.71e-05	0.00341	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKR1B1—uterine cancer	7.6e-05	0.00336	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—STAR—uterine cancer	7.6e-05	0.00336	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—RRM2—uterine cancer	7.52e-05	0.00333	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—RRM2—uterine cancer	7.52e-05	0.00333	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—DCN—uterine cancer	7.49e-05	0.00331	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—DCN—uterine cancer	7.3e-05	0.00323	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—DCN—uterine cancer	7.3e-05	0.00323	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKR1C1—uterine cancer	7.3e-05	0.00323	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—STAR—uterine cancer	7.29e-05	0.00322	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKR1B1—uterine cancer	7.29e-05	0.00322	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	7.1e-05	0.00314	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CYP11A1—uterine cancer	7.06e-05	0.00312	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—RRM2—uterine cancer	7.02e-05	0.00311	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—RRM2—uterine cancer	7.02e-05	0.00311	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—MTHFR—uterine cancer	6.98e-05	0.00309	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP11A1—uterine cancer	6.88e-05	0.00304	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP11A1—uterine cancer	6.88e-05	0.00304	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—DCN—uterine cancer	6.81e-05	0.00302	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—DCN—uterine cancer	6.81e-05	0.00302	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	6.69e-05	0.00296	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKR1C3—uterine cancer	6.66e-05	0.00295	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—RRM2—uterine cancer	6.5e-05	0.00288	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKR1C3—uterine cancer	6.49e-05	0.00287	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKR1C3—uterine cancer	6.49e-05	0.00287	CbGpPWpGaD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	6.45e-05	0.00285	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP11A1—uterine cancer	6.42e-05	0.00284	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP11A1—uterine cancer	6.42e-05	0.00284	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—STAR—uterine cancer	6.4e-05	0.00283	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKR1B1—uterine cancer	6.4e-05	0.00283	CbGpPWpGaD
Acetazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	6.36e-05	0.00281	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—DCN—uterine cancer	6.31e-05	0.00279	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—POLD1—uterine cancer	6.22e-05	0.00275	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	6.22e-05	0.00275	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKR1C3—uterine cancer	6.06e-05	0.00268	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKR1C3—uterine cancer	6.06e-05	0.00268	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—MTHFR—uterine cancer	6.05e-05	0.00268	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN2A—uterine cancer	6e-05	0.00266	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—POLD1—uterine cancer	5.96e-05	0.00264	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP11A1—uterine cancer	5.95e-05	0.00263	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKR1C1—uterine cancer	5.82e-05	0.00257	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—POLD1—uterine cancer	5.72e-05	0.00253	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKR1C3—uterine cancer	5.62e-05	0.00249	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKR1C1—uterine cancer	5.58e-05	0.00247	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CXCL8—uterine cancer	5.44e-05	0.00241	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKR1C1—uterine cancer	5.35e-05	0.00237	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN1B—uterine cancer	5.31e-05	0.00235	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	5.22e-05	0.00231	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—STK11—uterine cancer	5.19e-05	0.0023	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CYP19A1—uterine cancer	5.19e-05	0.0023	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—RRM2—uterine cancer	5.19e-05	0.00229	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—STK11—uterine cancer	5.06e-05	0.00224	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—STK11—uterine cancer	5.06e-05	0.00224	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP19A1—uterine cancer	5.06e-05	0.00224	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP19A1—uterine cancer	5.06e-05	0.00224	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—DCN—uterine cancer	5.03e-05	0.00223	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—POLD1—uterine cancer	5.03e-05	0.00222	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—RRM2—uterine cancer	4.97e-05	0.0022	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—DCN—uterine cancer	4.83e-05	0.00214	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—RRM2—uterine cancer	4.77e-05	0.00211	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP11A1—uterine cancer	4.74e-05	0.0021	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—STK11—uterine cancer	4.72e-05	0.00209	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—STK11—uterine cancer	4.72e-05	0.00209	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP19A1—uterine cancer	4.72e-05	0.00209	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP19A1—uterine cancer	4.72e-05	0.00209	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKR1C1—uterine cancer	4.7e-05	0.00208	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—EP300—uterine cancer	4.67e-05	0.00206	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—DCN—uterine cancer	4.63e-05	0.00205	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	4.56e-05	0.00202	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP11A1—uterine cancer	4.55e-05	0.00201	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKR1C3—uterine cancer	4.48e-05	0.00198	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—VEGFA—uterine cancer	4.42e-05	0.00196	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—STK11—uterine cancer	4.38e-05	0.00194	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP19A1—uterine cancer	4.38e-05	0.00194	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP11A1—uterine cancer	4.36e-05	0.00193	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKR1C3—uterine cancer	4.29e-05	0.0019	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—RRM2—uterine cancer	4.19e-05	0.00185	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKR1C3—uterine cancer	4.12e-05	0.00182	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—DCN—uterine cancer	4.07e-05	0.0018	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	4.01e-05	0.00177	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—MTHFR—uterine cancer	3.9e-05	0.00173	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PTEN—uterine cancer	3.88e-05	0.00172	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP11A1—uterine cancer	3.83e-05	0.0017	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—MTHFR—uterine cancer	3.8e-05	0.00168	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—MTHFR—uterine cancer	3.8e-05	0.00168	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	3.77e-05	0.00167	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	3.72e-05	0.00165	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—EP300—uterine cancer	3.7e-05	0.00164	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKR1C3—uterine cancer	3.62e-05	0.0016	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—MTHFR—uterine cancer	3.55e-05	0.00157	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—MTHFR—uterine cancer	3.55e-05	0.00157	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	3.51e-05	0.00156	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—STK11—uterine cancer	3.49e-05	0.00154	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP19A1—uterine cancer	3.49e-05	0.00154	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PTEN—uterine cancer	3.37e-05	0.00149	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP19A1—uterine cancer	3.35e-05	0.00148	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—STK11—uterine cancer	3.35e-05	0.00148	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—TP53—uterine cancer	3.34e-05	0.00148	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—MTHFR—uterine cancer	3.29e-05	0.00146	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—EP300—uterine cancer	3.21e-05	0.00142	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—STK11—uterine cancer	3.21e-05	0.00142	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP19A1—uterine cancer	3.21e-05	0.00142	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—STK11—uterine cancer	2.82e-05	0.00125	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP19A1—uterine cancer	2.82e-05	0.00125	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.78e-05	0.00123	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CA—uterine cancer	2.74e-05	0.00121	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.74e-05	0.00121	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—MTHFR—uterine cancer	2.62e-05	0.00116	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—MTHFR—uterine cancer	2.51e-05	0.00111	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—MTHFR—uterine cancer	2.41e-05	0.00107	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CA—uterine cancer	2.38e-05	0.00105	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—AKT1—uterine cancer	2.24e-05	0.000991	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTEN—uterine cancer	2.17e-05	0.00096	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—MTHFR—uterine cancer	2.12e-05	0.000938	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTEN—uterine cancer	2.11e-05	0.000936	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTEN—uterine cancer	2.11e-05	0.000936	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—EP300—uterine cancer	2.07e-05	0.000916	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—EP300—uterine cancer	2.02e-05	0.000893	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—EP300—uterine cancer	2.02e-05	0.000893	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTEN—uterine cancer	1.97e-05	0.000874	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTEN—uterine cancer	1.97e-05	0.000874	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—AKT1—uterine cancer	1.94e-05	0.000859	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—EP300—uterine cancer	1.88e-05	0.000833	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—EP300—uterine cancer	1.88e-05	0.000833	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTEN—uterine cancer	1.83e-05	0.00081	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—EP300—uterine cancer	1.74e-05	0.000772	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CA—uterine cancer	1.53e-05	0.000678	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CA—uterine cancer	1.49e-05	0.00066	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CA—uterine cancer	1.49e-05	0.00066	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.49e-05	0.00066	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.49e-05	0.00066	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTEN—uterine cancer	1.46e-05	0.000646	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTEN—uterine cancer	1.4e-05	0.000619	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CA—uterine cancer	1.39e-05	0.000616	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CA—uterine cancer	1.39e-05	0.000616	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—EP300—uterine cancer	1.39e-05	0.000616	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTEN—uterine cancer	1.34e-05	0.000593	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—EP300—uterine cancer	1.33e-05	0.00059	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CA—uterine cancer	1.29e-05	0.000571	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—EP300—uterine cancer	1.28e-05	0.000566	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKT1—uterine cancer	1.25e-05	0.000554	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKT1—uterine cancer	1.22e-05	0.000539	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKT1—uterine cancer	1.22e-05	0.000539	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTEN—uterine cancer	1.18e-05	0.000522	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKT1—uterine cancer	1.14e-05	0.000504	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKT1—uterine cancer	1.14e-05	0.000504	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—EP300—uterine cancer	1.12e-05	0.000497	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.08e-05	0.000477	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—STAR—uterine cancer	1.08e-05	0.000477	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKT1—uterine cancer	1.05e-05	0.000467	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CA—uterine cancer	1.03e-05	0.000455	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CA—uterine cancer	9.87e-06	0.000437	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CA—uterine cancer	9.46e-06	0.000419	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—POLD1—uterine cancer	8.46e-06	0.000374	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKT1—uterine cancer	8.41e-06	0.000372	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CA—uterine cancer	8.32e-06	0.000368	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKT1—uterine cancer	8.06e-06	0.000357	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKR1C1—uterine cancer	7.91e-06	0.00035	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKT1—uterine cancer	7.73e-06	0.000342	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—RRM2—uterine cancer	7.05e-06	0.000312	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—DCN—uterine cancer	6.85e-06	0.000303	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKT1—uterine cancer	6.79e-06	0.000301	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP11A1—uterine cancer	6.45e-06	0.000286	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKR1C3—uterine cancer	6.09e-06	0.00027	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—STK11—uterine cancer	4.75e-06	0.00021	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.75e-06	0.00021	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—MTHFR—uterine cancer	3.57e-06	0.000158	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTEN—uterine cancer	1.98e-06	8.78e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—EP300—uterine cancer	1.89e-06	8.37e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.4e-06	6.2e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKT1—uterine cancer	1.14e-06	5.06e-05	CbGpPWpGaD
